Sponsored Links
| FDA Advisory Committee Votes In Favor Of Zyprexa For Two Adolescent Indications |
 |
 |
 |
| Medical News - Bipolar | |||
|
The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted that Zyprexa(R) (olanzapine), an atypical antipsychotic, is effective and acceptably safe for the acute treatment of schizophrenia or manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old. Read more: Bipolar News From Medical News Today
|